News
Jernigan Capital Q2 Earnings Call Highlights
Key Points
- Interested in Jernigan Capital, Inc.? Here are five stocks we like better.
- Second-quarter performance improved: Collections rose 18% year over year to $301 million, revenue increased
Deep Fission Targets 2027 Debut for Underground Nuclear Reactors
Key Points
- Interested in Deep Fission, Inc.? Here are five stocks we like better.
- Underground reactor model: Deep Fission plans to deploy existing pressurized water reactor technology in
Innventure Q2 Earnings Call Highlights
Key Points
- Interested in Innventure, Inc.? Here are five stocks we like better.
- Accelsius’ outlook was materially reduced: Innventure withdrew its prior forecast for near-breakeven cash flow and
Intellicheck Q2 Earnings Call Highlights
Key Points
- Interested in Intellicheck, Inc.? Here are five stocks we like better.
- Intellicheck reported solid second-quarter results, with revenue of $5.9 million, net income of $633,000, 91%
Health In Tech Q2 Earnings Call Highlights
Key Points
- Interested in Health In Tech, Inc.? Here are five stocks we like better.
- Q2 revenue fell 13.5% to $8.1 million, which management attributed to policy-recognition timing related to
Nu Holdings Ltd. (NU) Surpasses Q2 Earnings and Revenue Estimates
Nu Holdings Ltd. (NU) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.14 per share a year ago. These
Use This Zacks Tool to Find Strong Cloud Stocks
Zacks Thematic Screens lets you dive into 30 dynamic investment themes shaping the future. Whether you're interested in cutting-edge technology, renewable energy, or healthcare innovations, our
Afya (AFYA) Q2 Earnings and Revenues Lag Estimates
Afya (AFYA) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.4 per share a year ago. These figures are
NextNRG Inc. (NXXT) Reports Q2 Loss, Tops Revenue Estimates
NextNRG Inc. (NXXT) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.3 per share a year ago. These figures are
Blaize Holdings, Inc. (BZAI) Reports Q2 Loss, Lags Revenue Estimates
Blaize Holdings, Inc. (BZAI) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.28 per share a year ago. These
Heartflow Q2 Earnings Call Highlights
Key Points
- Interested in Heartflow, Inc.? Here are five stocks we like better.
- Strong second-quarter growth: Revenue rose 48% year over year to $64.1 million, while global case volume increased
Genasys Q3 Earnings Call Highlights
Key Points
- Interested in Genasys Inc.? Here are five stocks we like better.
- Revenue fell to $7.3 million from $9.9 million year over year due to temporary supply-chain issues affecting the
FitLife Brands Q2 Earnings Call Highlights
Key Points
- Interested in FitLife Brands Inc.? Here are five stocks we like better.
- Second-quarter revenue rose 65% year over year to $26.5 million, driven by the Irwin Naturals acquisition
Eton Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Eton Pharmaceuticals, Inc.? Here are five stocks we like better.
- Revenue and profitability surged: Second-quarter revenue nearly doubled to $37.6 million, while adjusted
FocalTherics Q2 Earnings Call Highlights
Key Points
- Interested in FocalTherics? Here are five stocks we like better.
- HIFU growth accelerated: Second-quarter HIFU revenue rose 39% year over year to $13.2 million, supported by 13 Focal
Digimarc Q2 Earnings Call Highlights
Key Points
- Interested in Digimarc Corporation? Here are five stocks we like better.
- Digimarc is restructuring its commercial operations around retail and consumer packaged goods (CPG), where
Afya Q2 Earnings Call Highlights
Key Points
- Interested in Afya Limited? Here are five stocks we like better.
- Afya delivered solid first-half growth: Revenue rose 7% to BRL 1.985 billion, net income increased 7% to BRL 463
DLocal Q2 Earnings Call Highlights
Key Points
- Interested in DLocal Limited? Here are five stocks we like better.
- DLocal delivered record second-quarter results: Total payment volume surged 92% year over year to $17.7 billion
RCM Technologies, Inc. (RCMT) Q2 Earnings and Revenues Beat Estimates
RCM Technologies, Inc. (RCMT) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.54 per share. This compares to earnings of $0.69 per share a year ago
VIQ SOLUTIONS (VQSSF) Q2 Earnings and Revenues Beat Estimates
VIQ SOLUTIONS (VQSSF) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to a loss of $0.02 per share a year ago
BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Misses Revenue Estimates
BioXcel Therapeutics, Inc. (BTAI) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to a loss of $2.45 per share a year ago
EZCORP Eyes Faster Expansion After Record Quarter, SMG Deal
Key Points
- Interested in EZCORP, Inc.? Here are five stocks we like better.
- Record quarterly performance drove EZCORP’s growth, with adjusted EBITDA up 48% and adjusted EPS up 47%. The company
CapsoVision Q2 Earnings Call Highlights
Key Points
- Interested in CapsoVision, Inc.? Here are five stocks we like better.
- Second-quarter revenue rose 10% to $3.6 million, driven by a 13% increase in CapsoCam Plus capsule sales and
Cineverse Q1 Earnings Call Highlights
Key Points
- Interested in Cineverse Corp.? Here are five stocks we like better.
- Revenue surged 175% to $30.6 million in fiscal Q1 2027 following the Giant Worldwide and IndiCue acquisitions
Celcuity Q2 Earnings Call Highlights
Key Points
- Interested in Celcuity, Inc.? Here are five stocks we like better.
- REVTORPYK launch remains on track: Celcuity expects commercial shipments of its FDA-approved gedatolisib therapy for